FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225302797> ?p ?o ?g. }

• W4225302797 endingPage "529" @default.
• W4225302797 startingPage "529" @default.
• W4225302797 abstract "Limited data are available regarding long-term clinical outcomes of iliac artery endovascular therapy (EVT) in real-world practice. This study investigated long-term outcomes according to Trans-Atlantic Inter-Society Consensus (TASC) classifications.We analyzed data from 1,705 limbs of 1,364 patients from the retrospective cohort of the multicenter Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Disease registry. The primary endpoint was target lesion revascularization (TLR)-free survival.TASC A, B, C, and D lesions were present in 19.4%, 26.2%, 28.7%, and 25.7% of the treated limbs, respectively. The technical success rate was 96.2% and did not differ between TASC lesion types. Complications occurred in 6.8% of cases and more occurred in TASC D (11.8%). Iliac artery EVT showed a 5-year TLR-free survival of 89.2%. The TASC D group had the lowest TLR-free rate of 79.3%. TASC D (hazard ratio [HR], 1.75; 95% confidence interval [CI], 1.12-2.73; p=0.014), plain old balloon angioplasty (HR, 4.25; 95% CI, 2.03-8.88; p<0.001), current smoker (HR, 1.89; 95% CI, 1.26-2.83; p=0.002), previous bypass surgery (HR, 3.04; 95% CI, 1.28-7.19; p=0.011), combined femoropopliteal treatment (HR, 4.89; 95% CI, 3.19-7.50; p<0.001), combined below the knee treatment (HR, 2.20; 95% CI, 1.25-3.89; p=0.007), and complications (HR, 1.86; 95% CI, 1.07-3.24; p=0.028) were predictors for TLR.Iliac artery EVT achieved excellent technical success and 5-year TLR-free survival. TASC D showed a favorable but lower 5-year TLR-free survival rate and higher complication rate compared with other TASC groups.ClinicalTrials.gov Identifier: NCT02748226." @default.
• W4225302797 created "2022-05-05" @default.
• W4225302797 creator A5012918239 @default.
• W4225302797 creator A5016198765 @default.
• W4225302797 creator A5022383639 @default.
• W4225302797 creator A5022612041 @default.
• W4225302797 creator A5034687612 @default.
• W4225302797 creator A5046785179 @default.
• W4225302797 creator A5055429852 @default.
• W4225302797 creator A5057645077 @default.
• W4225302797 creator A5066270594 @default.
• W4225302797 creator A5071199634 @default.
• W4225302797 creator A5081680751 @default.
• W4225302797 creator A5082209040 @default.
• W4225302797 creator A5086178193 @default.
• W4225302797 creator A5087846202 @default.
• W4225302797 date "2022-01-01" @default.
• W4225302797 modified "2023-10-18" @default.
• W4225302797 title "Long-Term Clinical Outcomes of Iliac Artery Endovascular Therapy in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry" @default.
• W4225302797 cites W1948229862 @default.
• W4225302797 cites W1971930220 @default.
• W4225302797 cites W1983833067 @default.
• W4225302797 cites W1994690747 @default.
• W4225302797 cites W2039938078 @default.
• W4225302797 cites W2043018443 @default.
• W4225302797 cites W2078178450 @default.
• W4225302797 cites W2123874951 @default.
• W4225302797 cites W2144985796 @default.
• W4225302797 cites W2165276747 @default.
• W4225302797 cites W2299725291 @default.
• W4225302797 cites W2556838984 @default.
• W4225302797 cites W2606775369 @default.
• W4225302797 cites W2964193153 @default.
• W4225302797 cites W2975859535 @default.
• W4225302797 cites W3012023551 @default.
• W4225302797 cites W3126741179 @default.
• W4225302797 cites W3128877006 @default.
• W4225302797 cites W3183402545 @default.
• W4225302797 doi "https://doi.org/10.4070/kcj.2021.0390" @default.
• W4225302797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35491481" @default.
• W4225302797 hasPublicationYear "2022" @default.
• W4225302797 type Work @default.
• W4225302797 citedByCount "2" @default.
• W4225302797 countsByYear W42253027972022 @default.
• W4225302797 countsByYear W42253027972023 @default.
• W4225302797 crossrefType "journal-article" @default.
• W4225302797 hasAuthorship W4225302797A5012918239 @default.
• W4225302797 hasAuthorship W4225302797A5016198765 @default.
• W4225302797 hasAuthorship W4225302797A5022383639 @default.
• W4225302797 hasAuthorship W4225302797A5022612041 @default.
• W4225302797 hasAuthorship W4225302797A5034687612 @default.
• W4225302797 hasAuthorship W4225302797A5046785179 @default.
• W4225302797 hasAuthorship W4225302797A5055429852 @default.
• W4225302797 hasAuthorship W4225302797A5057645077 @default.
• W4225302797 hasAuthorship W4225302797A5066270594 @default.
• W4225302797 hasAuthorship W4225302797A5071199634 @default.
• W4225302797 hasAuthorship W4225302797A5081680751 @default.
• W4225302797 hasAuthorship W4225302797A5082209040 @default.
• W4225302797 hasAuthorship W4225302797A5086178193 @default.
• W4225302797 hasAuthorship W4225302797A5087846202 @default.
• W4225302797 hasBestOaLocation W42253027972 @default.
• W4225302797 hasConcept C126322002 @default.
• W4225302797 hasConcept C139059822 @default.
• W4225302797 hasConcept C141071460 @default.
• W4225302797 hasConcept C167135981 @default.
• W4225302797 hasConcept C168563851 @default.
• W4225302797 hasConcept C203092338 @default.
• W4225302797 hasConcept C207103383 @default.
• W4225302797 hasConcept C2776820930 @default.
• W4225302797 hasConcept C2778283817 @default.
• W4225302797 hasConcept C2778583881 @default.
• W4225302797 hasConcept C2779464278 @default.
• W4225302797 hasConcept C2780326628 @default.
• W4225302797 hasConcept C2780400711 @default.
• W4225302797 hasConcept C2781156865 @default.
• W4225302797 hasConcept C2781464078 @default.
• W4225302797 hasConcept C44249647 @default.
• W4225302797 hasConcept C500558357 @default.
• W4225302797 hasConcept C71924100 @default.
• W4225302797 hasConcept C72563966 @default.
• W4225302797 hasConceptScore W4225302797C126322002 @default.
• W4225302797 hasConceptScore W4225302797C139059822 @default.
• W4225302797 hasConceptScore W4225302797C141071460 @default.
• W4225302797 hasConceptScore W4225302797C167135981 @default.
• W4225302797 hasConceptScore W4225302797C168563851 @default.
• W4225302797 hasConceptScore W4225302797C203092338 @default.
• W4225302797 hasConceptScore W4225302797C207103383 @default.
• W4225302797 hasConceptScore W4225302797C2776820930 @default.
• W4225302797 hasConceptScore W4225302797C2778283817 @default.
• W4225302797 hasConceptScore W4225302797C2778583881 @default.
• W4225302797 hasConceptScore W4225302797C2779464278 @default.
• W4225302797 hasConceptScore W4225302797C2780326628 @default.
• W4225302797 hasConceptScore W4225302797C2780400711 @default.
• W4225302797 hasConceptScore W4225302797C2781156865 @default.
• W4225302797 hasConceptScore W4225302797C2781464078 @default.
• W4225302797 hasConceptScore W4225302797C44249647 @default.
• W4225302797 hasConceptScore W4225302797C500558357 @default.
• W4225302797 hasConceptScore W4225302797C71924100 @default.

• next